Applies to methscopolamine: oral tablets.
Side effects include:
Xerostomia, decreased sweating, adverse ocular effects (e.g., blurred vision, mydriasis, cycloplegia, increased ocular tension).
For Healthcare Professionals
Applies to methscopolamine: oral tablet.
Cardiovascular
Frequency not reported: Tachycardia, palpitation[Ref]
Hypersensitivity
Frequency not reported: Severe allergic reaction or drug idiosyncrasies including anaphylaxis[Ref]
Nervous system
Frequency not reported: Headaches, drowsiness, dizziness, loss of taste[Ref]
Ocular
Frequency not reported: Blurred vision, dilatation of the pupil, cycloplegia, increased ocular tension[Ref]
Gastrointestinal
Frequency not reported: Nausea, vomiting, constipation, bloated feeling, xerostomia[Ref]
Dermatologic
Frequency not reported: Decreased sweating, urticaria and other dermal manifestations[Ref]
Genitourinary
Frequency not reported: Urinary hesitancy and retention, impotence, suppression of lactation[Ref]
Other
Frequency not reported: Weakness[Ref]
Psychiatric
Frequency not reported: Nervousness, mental confusion, insomnia[Ref]
